Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4M8H

CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH (R)4-METHYL 9cUAB30 AND COACTIVATOR PEPTIDE GRIP-1

4M8H の概要
エントリーDOI10.2210/pdb4m8h/pdb
関連するPDBエントリー3OAP 4K4J 4M8E
分子名称Retinoic acid receptor RXR-alpha, Nuclear receptor coactivator 2, (2E,6Z,8E)-3,7-dimethyl-8-[(4R)-4-methyl-3,4-dihydronaphthalen-1(2H)-ylidene]octa-2,6-dienoic acid, ... (4 entities in total)
機能のキーワードantiparallel sandwich, ligand binding, coactivator binding, dimerization, activation function, transcription, nuclear receptors, ligand binding domain, ligand binding pocket, coactivator binding site, cancer, (r)4-methyl uab30 [(2e, 4e, 6z, 8e)-8-[(4'r)methyl-3', 4'-dihydro-1'(2'h)-naphthalen-1'-ylidene]-3, 7-dimethyl-2, 4, 6-octatrienoic acid]
由来する生物種Homo sapiens (human)
詳細
細胞内の位置Nucleus: P19793 Q15596
タンパク質・核酸の鎖数2
化学式量合計27613.16
構造登録者
Xia, G.,Smith, C.D.,Muccio, D.D. (登録日: 2013-08-13, 公開日: 2014-01-22, 最終更新日: 2023-09-20)
主引用文献Desphande, A.,Xia, G.,Boerma, L.J.,Vines, K.K.,Atigadda, V.R.,Lobo-Ruppert, S.,Grubbs, C.J.,Moeinpour, F.L.,Smith, C.D.,Christov, K.,Brouillette, W.J.,Muccio, D.D.
Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention.
Bioorg.Med.Chem., 22:178-185, 2014
Cited by
PubMed Abstract: (2E,4E,6Z,8Z)-8-(3',4'-Dihydro-1'(2H)-naphthalen-1'-ylidene)-3,7-dimethyl-2,3,6-octatrienoinic acid, 9cUAB30, is a selective rexinoid for the retinoid X nuclear receptors (RXR). 9cUAB30 displays substantial chemopreventive capacity with little toxicity and is being translated to the clinic as a novel cancer prevention agent. To improve on the potency of 9cUAB30, we synthesized 4-methyl analogs of 9cUAB30, which introduced chirality at the 4-position of the tetralone ring. The syntheses and biological evaluations of the racemic homolog and enantiomers are reported. We demonstrate that the S-enantiomer is the most potent and least toxic even though these enantiomers bind in a similar conformation in the ligand binding domain of RXR.
PubMed: 24359708
DOI: 10.1016/j.bmc.2013.11.039
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.2 Å)
構造検証レポート
Validation report summary of 4m8h
検証レポート(詳細版)ダウンロードをダウンロード

239492

件を2025-07-30に公開中

PDB statisticsPDBj update infoContact PDBjnumon